Loading…
Axogen, Inc. is projected to rise to $56.24 by 2027, a +41% move from its current price of $39.87. AXGN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $39.00 | $39.91 | $40.84 | +0.10% |
| May 30 | $38.66 | $39.95 | $41.28 | +0.20% |
| May 31 | $38.42 | $39.99 | $41.62 | +0.30% |
| Jun 1 | $38.22 | $40.03 | $41.92 | +0.40% |
| Jun 2 | $38.05 | $40.07 | $42.19 | +0.50% |
| Jun 3 | $37.90 | $40.11 | $42.44 | +0.59% |
| Jun 4 | $37.76 | $40.15 | $42.68 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $37.76 | $40.15 | $42.68 | +0.69% |
| Week 2 | $37.07 | $40.43 | $44.08 | +1.39% |
| Week 3 | $36.61 | $40.71 | $45.26 | +2.10% |
| Week 4 | $36.27 | $40.99 | $46.32 | +2.80% |
| Week 5 | $35.99 | $41.27 | $47.32 | +3.52% |
| Week 6 | $35.77 | $41.56 | $48.28 | +4.24% |
| Week 7 | $35.59 | $41.85 | $49.20 | +4.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Axogen, Inc. is a healthcare company that develops and commercializes technologies used for peripheral nerve regeneration and repair worldwide. Its product portfolio includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, Avive+ Soft Tissue Matrix, and Avance Method, along with peripheral nerve tissue recovery and processing.
The company sells to hospitals, surgery centers and military hospitals through independent in-country distributors and is headquartered in Alachua, Florida.
Axogen, Inc. (AXGN) is a healthcare stock, currently trading at $40.90. This position reflects its standing within the healthcare sector as a provider of regenerative nerve technologies.
Its market capitalization is $2.17B and its current rank is 1942, highlighting its size relative to the broader market. Near-term technical lines show a bullish tilt, with RSI14 at 50 and the price trading above the SMA50 of $37.02 and above the SMA200 of $28.00. The 30-day price range runs from $35.20 to $47.52, with a near-term support at $33.47 and a resistance at $43.74.
The longer-range forecast implies a growing price outlook, with the 2026-2050 averages rising from $40.90 to $113.35, then to $844.70, while maximums extend to as high as $1,465.70 over the horizon.
A major floor 28.4% below — a decisive break under it would weaken the trend.
The nearest floor, 12.8% below — buyers have tended to step in here.
The nearest ceiling, 9.7% above — a clean break opens room to run.
A major ceiling 21.5% above — clearing it would confirm fresh momentum.
Key AXGN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AXGN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $41.24 | Sell | $40.96 | Sell |
| MA 10 | $41.31 | Sell | $41.24 | Sell |
| MA 20 | $41.92 | Sell | $40.84 | Sell |
| MA 50 | $37.34 | Buy | $38.33 | Buy |
| MA 100 | $34.99 | Buy | $35.02 | Buy |
| MA 200 | $28.27 | Buy | $29.91 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.20 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -137.42 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.47 | Sell |
| ROC (12) | -5.21 | Sell |
| Bollinger %B (20,2) | 0.05 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.55 | Buy |
| Awesome (5,34) | 1.54 | Buy |
| Ultimate (7,14,28) | 39.80 | Neutral |
| Momentum (10) | -1.06 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 40.70 | Sell |
| ADX (14) | 19.84 | Neutral |
| ATR (14) | 0.82 | Info |
The 30-day technical picture shows bullish momentum, with RSI14 at 50 signaling neutral to modestly constructive momentum. Prices are above the SMA50 of $37.02, while the SMA200 sits at $28.00, suggesting the near-term trend is supported by both short- and long-term moving averages. The 30-day range spans $35.20 to $47.52, with a defined intra-range support at $33.47 and resistance at $43.74.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $28.55 | $39.87 | $58.72 | 0% | Neutral | |
| $45.27 | $56.24 | $73.62 | +41% | Bullish | |
| $61.44 | $78.08 | $105.40 | +96% | Bullish | |
| $76.25 | $98.74 | $136.62 | +148% | Bullish | |
| $84.57 | $111.35 | $157.31 | +179% | Bullish | |
| $96.57 | $129.11 | $185.77 | +224% | Bullish | |
| $103.49 | $140.32 | $205.26 | +252% | Bullish | |
| $119.18 | $163.75 | $243.15 | +311% | Bullish | |
| $149.68 | $208.24 | $313.53 | +422% | Bullish | |
| $164.87 | $232.13 | $354.04 | +482% | Bullish | |
| $270.80 | $402.40 | $648.02 | +909% | Bullish | |
| $519.33 | $845.50 | $1,475.09 | +20.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $28.55 | $39.87 | $46.83 | +0.00% |
| June 2026 | $35.67 | $41.75 | $49.92 | +4.71% |
| July 2026 | $37.01 | $43.63 | $52.77 | +4.50% |
| August 2026 | $37.15 | $44.04 | $53.75 | +0.95% |
| September 2026 | $37.85 | $45.07 | $55.40 | +2.34% |
| October 2026 | $39.41 | $47.13 | $58.31 | +4.57% |
| November 2026 | $39.63 | $47.57 | $59.19 | +0.93% |
| December 2026 | $38.97 | $46.94 | $58.72 | -1.33% |
Click any year to see its month-by-month AXGN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AXGN to range from $28.55 to $58.72 through 2026. The $39.87 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AXGN price prediction for 2027 points to an average of $56.24 (low $45.27, high $73.62) — a potential gain of +41% on today's $39.87. Momentum favours further upside here.
In 2028, AXGN is projected to trade between $61.44 and $105.40, averaging $78.08 — a potential gain of +96% from today's $39.87. That is up +39% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Axogen, Inc.'s 2029 outlook centres on $98.74, within a $76.25 to $136.62 range. That is up +26% on the projected 2028 average. That marks a +148% change versus current levels. Momentum favours further upside here.
By 2030, AXGN could reach as high as $157.31, with a base case around $111.35 and support toward $84.57 — roughly +179% from $39.87. Buyers look set to stay in control over this stretch.
Expect AXGN to range from $96.57 to $185.77 through 2031. The $129.11 average target implies a +224% move from current prices. That is up +16% on the projected 2030 average. Momentum favours further upside here.
The AXGN price prediction for 2032 points to an average of $140.32 (low $103.49, high $205.26) — a potential gain of +252% on today's $39.87. Buyers look set to stay in control over this stretch.
In 2033, AXGN is projected to trade between $119.18 and $243.15, averaging $163.75 — a potential gain of +311% from today's $39.87. That is up +17% on the projected 2032 average. Momentum favours further upside here.
Axogen, Inc.'s 2034 outlook centres on $208.24, within a $149.68 to $313.53 range. That is up +27% on the projected 2033 average. That marks a +422% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AXGN could reach as high as $354.04, with a base case around $232.13 and support toward $164.87 — roughly +482% from $39.87. Momentum favours further upside here.
Expect AXGN to range from $270.80 to $648.02 through 2040. The $402.40 average target implies a +909% move from current prices. That is up +73% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AXGN price prediction for 2050 points to an average of $845.50 (low $519.33, high $1,475.09) — a potential gain of +20.2x on today's $39.87. Momentum favours further upside here.
Investing $1,000 in AXGN today (≈ 25.081515 AXGN) could be worth
$21,206.51
+$20,206.51 (+2021%) by 2050 · US Dollar
Based on the average projected AXGN price of $845.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AXGNwould be worth at today's price.
$1,000 invested in AXGN on May 27, 2025 (≈ 88.495574 AXGN) would be worth
$3,528.32
+$2,528.32 (+252.8%) today · 3.53× · US Dollar
Based on a AXGN entry price of $11.3 vs. today's $39.87.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $42.69 | $933.94 | -6.6% |
| 1 month ago | $39.39 | $1,012.19 | +1.2% |
| 3 months ago | $31.9 | $1,249.84 | +25.0% |
| 6 months ago | $28.65 | $1,391.62 | +39.2% |
| 1 year ago | $11.3 | $3,528.32 | +252.8% |
| All time (5.0y) ago | $19.76 | $2,017.71 | +101.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AXGN forecast.
Our base-case forecast reaches $80.00 around 2029.
Implied market cap at $80.00: $4.25B
The multi-year forecast outlines a bullish trajectory across the horizon, with rising averages and substantial upside potential. The projection for 2030 shows an average of $113.35, with a min of $86.27 and a max of $159.71, representing an implied ROI of 177.2% and a bullish sentiment. In 2040, the average is projected to be $405.24, with a min of $273.98 and a max of $649.67, for an ROI of 890.8% and continued bullish sentiment.
By 2050, the average is forecast at $844.70, with a min of $522.33 and a max of $1,465.70, yielding an ROI of 1965.3% and a persistently bullish stance.
Tap a question to reveal the answer.
Avg $113.35, min $86.27, max $159.71; ROI 177.2%; sentiment BULLISH.
Forecasts show bullish sentiment across years including 2030 and beyond, with rising averages (e.g., 2027 $58.14, 2028 $79.80, 2029 $100.55, 2030 $113.35); these are estimates, not guarantees.
Yes—the 2029 forecast lists min $77.79, avg $100.55, max $138.79, with an implied ROI of 145.8% and bullish sentiment.
Current price is $40.90 and market cap is $2.17B.
Bullish sentiment with RSI 50; SMA50 is $37.02 and SMA200 is $28.00; a support level of $33.47 and resistance at $43.74; 30-day range from $35.20 to $47.52.
Axogen, Inc. Community Discussion
0Share your Axogen, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.